Cleared Traditional

K071299 - IP SYSTEM

K071299 is an FDA 510(k) clearance for IP SYSTEM, manufactured by Digital Healthcare, Ltd.. The device is a Class 2 Ophthalmic device with product code NFJ cleared through the Traditional 510(k) pathway after a 114-day FDA review.

K071299 · Digital Healthcare, Ltd. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2007
Decision
114d
Days
Class 2
Risk

K071299 is an FDA 510(k) clearance for the IP SYSTEM, OCULAB IP, OPTOMIZE IP, RETASURE IP. Classified as System, Image Management, Ophthalmic (product code NFJ), Class II - Special Controls.

Submitted by Digital Healthcare, Ltd. (Wake Forest, US). The FDA issued a Cleared decision on August 31, 2007 after a review of 114 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 892.2050 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Digital Healthcare, Ltd. devices

FDA 510(k) Submission Details - K071299

510(k) Number K071299 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2007
Decision Date August 31, 2007
Days to Decision 114 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
4d slower than avg
Panel avg: 110d · This submission: 114d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NFJ Device Classification - Class 2, Special Controls

Product Code NFJ System, Image Management, Ophthalmic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.